EDAP TMS reported EUR-4.92M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AngioDynamics USD 5.94M 3.78M Sep/2025
Boston Scientific USD 1.37B 1000K Sep/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Henry Schein USD 291M 4M Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Veracyte USD 42.31M 2.58M Dec/2025